SP

Steve Paul

President of Research & Development and Chief Scientific Officer at Karuna Therapeutics, Inc

United States

Investor
VC
Angel

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Research
Teaching
Biotechnology
Strategic Planning
Lifesciences
Clinical Research
Genetics

Education

Investments

Rapport Therapeutics

Series A

Total Funding: $250M

Karuna Therapeutics

Series A

Total Funding: $110M

SAGE Therapeutics

Series C

Total Funding: $58M

Voyager Therapeutics

Series A

Total Funding: $45M

Work Experience

Karuna Therapeutics

2023

  • President of Research & Development and Chief Scientific Officer

    2023

Karuna Therapeutics, Inc

2018

  • CEO and Chairman of the Board

    2018

Voyager Therapeutics, Inc.

2018

  • Senior Advisor, Co-founder and Board Member

    2018

Voyager Therapeutics, Inc.

2014 - 2018

  • CEO

    2014 - 2018